With climate change driving an increasingly stronger influence over governments and municipalities, sustainable development, and renewable energy are gaining traction across the globe. This is reflected within the EU 2030 agenda, that envisions a future where there is universal access to affordable, reliable and sustainable energy. One of the challenges to achieve this vision lies on the low reliability of certain renewable sources. While both particulars and public entities try to reach self-sufficiency through sustainable energy generation, it is unclear how much investment is needed to mitigate the unreliability introduced by natural factors such as varying wind speed and daylight across the year. In this sense, a tool that aids predicting the energy output of sustainable sources across the year for a particular location can aid greatly in making sustainable energy investments more efficient. In this paper, we make use of Open Data sources, Internet of Things (IoT) sensors and installations distributed across Europe to create such tool through the application of Artificial Neural Networks. We analyze how the different factors affect the prediction of energy production and how Open Data can be used to predict the expected output of sustainable sources. As a result, we facilitate users the necessary information to decide how much they wish to invest according to the desired energy output for their particular location. Compared to state-of-the-art proposals, our solution provides an abstraction layer focused on energy production, rather that radiation data, and can be trained and tailored for different locations using Open Data. Finally, our tests show that our proposal improves the accuracy of the forecasting, obtaining a lower mean squared error (MSE) of 0.040 compared to an MSE 0.055 from other proposals in the literature.
Patients affected by SARS-COV-2 have collapsed healthcare systems around the world. Consequently, different challenges arise regarding the prediction of hospital needs, optimization of resources, diagnostic triage tools and patient evolution, as well as tools that allow us to analyze which are the factors that determine the severity of patients. Currently, it is widely accepted that one of the problems since the pandemic appeared was to detect (i) who patients were about to need Intensive Care Unit (ICU) and (ii) who ones were about not overcome the disease. These critical patients collapsed Hospitals to the point that many surgeries around the world had to be cancelled. Therefore, the aim of this paper is to provide a Machine Learning (ML) model that helps us to prevent when a patient is about to be critical. Although we are in the era of data, regarding the SARS-COV-2 patients, there are currently few tools and solutions that help medical professionals to predict the evolution of patients in order to improve their treatment and the needs of critical resources at hospitals. Moreover, most of these tools have been created from small populations and/or Chinese populations, which carries a high risk of bias. In this paper, we present a model, based on ML techniques, based on 5378 Spanish patients’ data from which a quality cohort of 1201 was extracted to train the model. Our model is capable of predicting the probability of death of patients with SARS-COV-2 based on age, sex and comorbidities of the patient. It also allows what-if analysis, with the inclusion of comorbidities that the patient may develop during the SARS-COV-2 infection. For the training of the model, we have followed an agnostic approach. We explored all the active comorbidities during the SARS-COV-2 infection of the patients with the objective that the model weights the effect of each comorbidity on the patient’s evolution according to the data available. The model has been validated by using stratified cross-validation with k = 5 to prevent class imbalance. We obtained robust results, presenting a high hit rate, with 84.16% accuracy, 83.33% sensitivity, and an Area Under the Curve (AUC) of 0.871. The main advantage of our model, in addition to its high success rate, is that it can be used with medical records in order to predict their diagnosis, allowing the critical population to be identified in advance. Furthermore, it uses the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD 9-CM) standard. In this sense, we should also emphasize that those hospitals using other encodings can add an intermediate layer business to business (B2B) with the aim of making transformations to the same international format.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.